XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,419,416 | -11.3% | 100,100 | 0.0% | 0.01% | -9.1% |
| Q2 2023 | $3,853,850 | +47.5% | 100,100 | +37.1% | 0.01% | +37.5% |
| Q1 2023 | $2,612,670 | +39.8% | 73,000 | +54.0% | 0.01% | +33.3% |
| Q4 2022 | $1,868,982 | +88.2% | 47,400 | +72.4% | 0.01% | +100.0% |
| Q3 2022 | $993,000 | +48.4% | 27,500 | +25.0% | 0.00% | +50.0% |
| Q2 2022 | $669,000 | -47.9% | 22,000 | -47.6% | 0.00% | -33.3% |
| Q1 2022 | $1,284,000 | -2.1% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,312,000 | – | 42,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |